New wearable device aims to ease lymphedema swelling

NCT ID NCT04897035

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a wearable compression device called Dayspring for people with lymphedema in one leg. 24 adults used the device daily for 3 months. Researchers measured changes in leg swelling and quality of life to see if the device was safe and helpful.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Dayspring Active Wearable Compression System (a wearable compression device)
What this could lead to
If it works, this could offer a more convenient, active way to manage lymphedema swelling and improve quality of life without traditional bandages.
What could go wrong
This was a small, non-randomized study with only 24 people, so results may not apply to everyone. The device requires daily use, and individual results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC VENOUS INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ginger-K Lymphedema & Cancer Center

    Morgan Hill, California, 95037, United States

  • PT works

    Los Altos, California, 94024, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.